Your browser doesn't support javascript.
Severe urticarial rash as the initial symptom of COVID-19 infection.
Pagali, Sandeep; Parikh, Riddhi S.
  • Pagali S; Department of Medicine, Division of Hospital Internal Medicine & Division of Geriatric Medicine and Gerontology, Mayo Clinic, Rochester, Minnesota, USA pagali.sandeep@mayo.edu.
  • Parikh RS; Department of Medicine, Division of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
BMJ Case Rep ; 14(3)2021 Mar 25.
Article in English | MEDLINE | ID: covidwho-1153657
ABSTRACT
A 54-year-old woman presented with pruritic rash and hives of 3 days' duration followed by shortness of breath for 1 day. SARS-CoV-2 PCR test for COVID-19 was positive. Cutaneous manifestations of COVID-19 include acral lesions, urticarial rash, erythematous maculopapular rash, vascular rashes and vesicular rash. The cutaneous manifestations are mostly described as self-limiting. Urticarial rashes are not reported as the initial presentation symptom of COVID-19 infection but mostly noted to occur at the same time or after the onset of non-cutaneous symptoms. Management of cutaneous manifestations of COVID-19 affecting quality of life has not been well studied. Antihistamine therapy is the primary recommended therapy. Role of antiviral therapy for severe cases of rash needs to be further assessed.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Exanthema / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Bcr-2021-241793

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Exanthema / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Female / Humans / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Bcr-2021-241793